In Vitro Antibody Discovery and the Potential Value of AI: The AIntibody Challenge

A growing number of methods now enable access to rich sequence sets of target-specific antibodies. However, differences in quality, diversity and speed can be difficult to interpret. Tools such as high-throughput surface plasmon resonance (HT-SPR) are proving essential in accessing and understanding these outputs.

Watch as our experts examine the inaugural AIntibody Challenge, which benchmarked the potential value of AI in antibody discovery, as well as explore state-of-the-art library approaches. They will also discuss the use of HT-SPR to profile immune repertoires from malaria patients, assess polyreactivity, and evaluate antibody binding activity and quality.

Watch this webinar to:

• Discover the power of the in vitro Specifica Generation 3 platform in antibody discovery
• Understand the effectiveness of AI in antibody affinity maturation and discovery
• Learn about the use of HT-SPR to provide rich pictures of immune repertoire kinetic and epitope diversity
• Gain further insights into the use of HT-SPR to identify potential quality issues of antibodies, polyspecificity and specific activit

Speakers:

Andrew Bradbury, PhD, MD
Chief Scientific Officer
Specifica, an IQVIA business

Daniel Bedinger, PhD,
Sr. Manager Field Application Science
Carterra